000 04498nam a22003617a 4500
008 240723s20242024 xxu||||| |||| 00| 0 eng d
040 _aOvid MEDLINE(R)
099 _a38620346
251 _aPatient-Centered Outcomes Research Institute (PCORI). PCORI Final Research Reports2019 04
252 _aPatient-Centered Outcomes Research Institute (PCORI). PCORI Final Research Reports2019 04, Katz RJ, Magee MF, Nunlee-Bland G, Johnson P, Witkin L, Nassar C, Bourges C, Brown K, Cohen J, Cioletti A, Getaneh A, Young H, Payne D, Hopkins A, Mavritte T
260 _c2019
260 _p2019 04
265 _sppublish
266 _d2024-07-23
520 _aBACKGROUND: Diabetes mellitus (DM) is a complex chronic disease with less than 63% of patients achieving a target HbA1c <7% and only 7% meeting combined glycemic, lipid, and blood pressure (BP) goals. Both community health workers (CHWs) and mobile health (mHealth) have the potential to improve patient-health care team communication and improve patient self-management.
520 _aMETHODS: A total of 166 Medicaid patients with type 2 DM, HbA1c >8.0%, with 3 or more out of 13 unmet wellness and clinical goals were randomized into 3 groups: Group 1 (n = 56) was assisted by the Voxiva Care4Life diabetes mHealth system (C4L) alone; group 2 (n = 56) was assisted by a CHW only; and group 3 (n = 54) had both C4L and a CHW. We recruited participants from the outpatient clinics of 3 Washington, DC, medical centers. We followed these participants for 12 months, comparing achievement of wellness behaviors and clinical outcome goals across the 3 health care strategies.
520 _aOBJECTIVES: We evaluated innovative strategies to improve care of DM for Medicaid patients using a cell phone (mHealth) and a CHW. We hypothesized that (1) mHealth plus a CHW is superior to the benefits of mHealth alone or a CHW alone; and (2) mHealth alone will improve self-management and DM outcomes compared with baseline. Our primary end point was increased achievement of wellness behaviors and clinical goals. Secondary end points included (1) HbA1c; (2) medical use (emergency department [ED] visits, hospitalizations, urgent office visits); (3) Low-density lipoprotein (LDL) cholesterol; (4) BP; (5) medication adherence; (6) diet, exercise, blood glucose monitoring, and BP testing; and (7) diabetes distress.
520 _aRESULTS: We saw the primary end point, increased number of met wellness and clinical goals, in all 3 groups (mean, 1.4 additional goals; P = .001). On average, groups improved goals met by 20% from baseline. Only 11 (6.6%) participants dropped out. At 12 months, HbA1c dropped 1.2% (P < .0001; nonsignificant difference across groups). Of the total participants, 51% achieved an HbA1c <9% and 30% achieved an HbA1c <8%. We observed improvements in medication adherence (P = .02), hospitalizations (P = .03), urgent care visits (P = .03), and diabetes distress (P < .0001), with no significant difference across groups. C4L use was sustained over 12-month follow-up, with participants receiving a mean 3.75 messages from C4L/day. Participants sent a median 3.9 messages into C4L /week. We saw a trend for higher participant-to-C4L messaging in the C4L + CHW group. Patient engagement with C4L weekly nonglucose measures (exercise, weight, medication adherence) was modest, with median response approximately 10 out of 52 weeks for all 3 groups. Participants were uniformly enthusiastic about participating in the program.
520 _aSUMMARY: The C4L + CHW strategy was not superior to C4L or CHW alone. All 3 approaches resulted in significant improvement of wellness and clinical goals, HbA1c, urgent health care use, and diabetes distress in an urban Medicaid population. The results of this study provide insight into the future use of CHWs and mHealth for the improvement of diabetes care. Copyright © 2019. George Washington University. All Rights Reserved.
546 _aEnglish
650 _aIN PROCESS -- NOT YET INDEXED
651 _aMedStar Diabetes Institute
651 _aMedStar Health Research Institute
651 _aMedStar Washington Hospital Center
657 _aReview
700 _aBourges, Clayton
700 _aBrown, Kristen
700 _aGetaneh, Asqual
700 _aMagee, Michelle
_bMHRI
700 _aNassar, Carine M
_bMWHC
856 _uhttps://dx.doi.org/10.25302/4.2019.IH.13046797
_zhttps://dx.doi.org/10.25302/4.2019.IH.13046797
942 _cART
_dArticle
999 _c14173
_d14173